KATRINA FOGEL: Open Payments
NPI 1871037663 · SILVER SPRINGS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $665 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $247 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Janssen Biotech, Inc. | 1 | $30 |
| PFIZER INC. | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
Products named: VRAYLAR, RINVOQ, CAPLYTA, TREMFYA, PREVNAR 20, PURIFIED CORTROPHIN GEL, SAPHNELO, BREZTRI.
Industry payments across NV — which companies pay providers there.
